Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine
WuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector
Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)
Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products
Nautilus Biotechnology Raises $76 Million in Series B Funding to Be the First to Quantify the Human Proteome
BC Platforms Aims to Advance Clinical Decision-Making by Enhancing Clinical Data with Genomics Information
Basepair Provides an Intuitive, Easy-to-Use NGS Data Analysis Platform Which Does Not Require Coding Skills